These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26411314)

  • 61. Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27.
    Strasser-Weippl K; Sudan G; Ramjeesingh R; Shepherd LE; O'Shaughnessy J; Parulekar WR; Liedke PER; Chen BE; Goss PE
    Eur J Cancer; 2018 Feb; 90():19-25. PubMed ID: 29274617
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.
    Fallowfield L; Cella D; Cuzick J; Francis S; Locker G; Howell A
    J Clin Oncol; 2004 Nov; 22(21):4261-71. PubMed ID: 15514369
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lobular carcinoma of the breast metastatic to the uterus in a patient under adjuvant anastrozole therapy.
    Erkanli S; Kayaselcuk F; Kuscu E; Bolat F; Sakalli H; Haberal A
    Breast; 2006 Aug; 15(4):558-61. PubMed ID: 16311034
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06).
    Takeuchi H; Takei H; Futsuhara K; Yoshida T; Kojima M; Kai T; Tabei T
    Int J Clin Oncol; 2014 Feb; 19(1):68-73. PubMed ID: 23314924
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients.
    Gervasini G; Jara C; Olier C; Romero N; Martínez R; Carrillo JA
    Br J Clin Pharmacol; 2017 Mar; 83(3):562-571. PubMed ID: 27747906
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy.
    Gallicchio L; Macdonald R; Wood B; Rushovich E; Helzlsouer KJ
    Breast Cancer Res Treat; 2011 Nov; 130(2):569-77. PubMed ID: 21647676
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature.
    Lycette JL; Luoh SW; Beer TM; Deloughery TG
    Breast Cancer Res Treat; 2006 Oct; 99(3):249-55. PubMed ID: 16752073
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
    Boccardo F; Rubagotti A; Puntoni M; Guglielmini P; Amoroso D; Fini A; Paladini G; Mesiti M; Romeo D; Rinaldini M; Scali S; Porpiglia M; Benedetto C; Restuccia N; Buzzi F; Franchi R; Massidda B; Distante V; Amadori D; Sismondi P
    J Clin Oncol; 2005 Aug; 23(22):5138-47. PubMed ID: 16009955
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anastrozole.
    Kelly CM; Buzdar AU
    Expert Opin Drug Saf; 2010 Nov; 9(6):995-1003. PubMed ID: 20923259
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aromatase inhibitors in the treatment of early and advanced breast cancer.
    Joensuu H; Ejlertsen B; Lønning PE; Rutqvist LE
    Acta Oncol; 2005; 44(1):23-31. PubMed ID: 15848903
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis.
    Lintermans A; Van Calster B; Van Hoydonck M; Pans S; Verhaeghe J; Westhovens R; Henry NL; Wildiers H; Paridaens R; Dieudonné AS; Leunen K; Morales L; Verschueren K; Timmerman D; De Smet L; Vergote I; Christiaens MR; Neven P
    Ann Oncol; 2011 Aug; 22(8):1763-9. PubMed ID: 21273342
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
    Borreani C; Alfieri S; Infante G; Miceli R; Mariani P; Bosisio M; Vernieri C; Bianchi GV; Capri G
    Oncology; 2021; 99(2):84-95. PubMed ID: 32992318
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rheumatoid arthritis and aromatase inhibitors.
    Bertolini E; Letho-Gyselinck H; Prati C; Wendling D
    Joint Bone Spine; 2011 Jan; 78(1):62-4. PubMed ID: 20621535
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Quality of life analysis of postmenopausal, early breast cancer patients treated with anastrozole (RADAR-II)].
    Horváth Z
    Magy Onkol; 2012 Dec; 56(4):242-6. PubMed ID: 23236594
    [TBL] [Abstract][Full Text] [Related]  

  • 76. COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy.
    Hadji P; Jackisch C; Bolten W; Blettner M; Hindenburg HJ; Klein P; König K; Kreienberg R; Rief W; Wallwiener D; Zaun S; Harbeck N
    Ann Oncol; 2014 Feb; 25(2):372-7. PubMed ID: 24355487
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
    Wagner LI; Zhao F; Goss PE; Chapman JW; Shepherd LE; Whelan TJ; Mattar BI; Bufill JA; Schultz WC; LaFrancis IE; Nagargoje GG; Vemuri R; Nikcevich DA; Sledge GW; Cella D
    Breast Cancer Res Treat; 2018 Jun; 169(3):537-548. PubMed ID: 29455298
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Hershman DL; Unger JM; Greenlee H; Capodice JL; Lew DL; Darke AK; Kengla AT; Melnik MK; Jorgensen CW; Kreisle WH; Minasian LM; Fisch MJ; Henry NL; Crew KD
    JAMA; 2018 Jul; 320(2):167-176. PubMed ID: 29998338
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial.
    Mao JJ; Farrar JT; Bruner D; Zee J; Bowman M; Seluzicki C; DeMichele A; Xie SX
    Cancer; 2014 Dec; 120(23):3744-51. PubMed ID: 25077452
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.
    Hershman DL; Unger JM; Crew KD; Awad D; Dakhil SR; Gralow J; Greenlee H; Lew DL; Minasian LM; Till C; Wade JL; Meyskens FL; Moinpour CM
    J Clin Oncol; 2015 Jun; 33(17):1910-7. PubMed ID: 25940724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.